Key result
Intermediate or high frailty risk linked to ~260% higher in-hospital mortality in Takotsubo cardiomyopathy.
Why the study?
Data on the prognostic value of frailty in patients with Takotsubo cardiomyopathy were scarce.
Does intermediate/high risk of frailty increase in-hospital mortality in adult patients with Takotsubo cardiomyopathy?
Observational (n=32,360)
Yes
Does intermediate/high risk of frailty increase in-hospital mortality in adult patients with Takotsubo cardiomyopathy?
Intermediate or high frailty risk is strongly associated with increased in-hospital mortality, cardiogenic shock, and stroke in patients admitted with Takotsubo cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Supports frailty assessment in Takotsubo admissions; leaves open whether targeted interventions improve outcomes.
BACKGROUND: There is scarce data on the prognostic value of frailty in patients with Takotsubo cardiomyopathy (TCM). This study aimed to assess the association between frailty and in-hospital outcomes in patients with TCM. METHODS: Adult admissions with TCM were included using the 2016-2019 National Inpatient Sample database. The primary outcome was in-hospital mortality and secondary outcomes included cardiogenic shock, in-hospital cardiac arrest, stroke/transient ischemic attack (TIA), length of hospital stay, and total charges. Frailty was assessed using the hospital frailty risk score (HFRS), and admissions were divided into two groups: low risk and intermediate/high risk of frailty. Logistic regression was used to estimate odds ratios (OR) with their 95% confidence intervals (CI). RESULTS: A total of 32 360 patients were included; the median age was 67 (58-76) years and 90% were female. The median HFRS was 2.6 (1.1-5.3). In the adjusted models, in-hospital mortality was significantly higher in the intermediate/high risk of frailty group (OR 3.60, 95% CI 2.16-6.02) compared to the low-risk group. Similarly, admissions with intermediate/high risk of frailty had a significantly higher risk of cardiogenic shock (OR 3.66, 95% CI 2.77-4.80), in-hospital cardiac arrest (OR 2.57, 95% CI 1.55-4.24), and stroke/TIA (OR 5.68, 95% CI 3.51-9.20). There was a significantly higher hospital charges and length of hospital stay in the intermediate/high-risk group. In the restricted cubic spline regression models, the frailty score was nonlinearly associated with all outcomes. CONCLUSIONS: Our results suggest that frailty is useful as a prognostic factor for in-hospital events in patients with TCM.
No takes yet. Share an insight, caveat, or question.
Díaz-Arocutipa et al. (2025) conducted an observational in Takotsubo cardiomyopathy (n=32,360). Intermediate/high risk of frailty vs. Low risk of frailty was evaluated on In-hospital mortality (OR 3.60, 95% CI 2.16-6.02). Intermediate/high risk of frailty was associated with higher in-hospital mortality compared to low risk of frailty in patients with Takotsubo cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: